Complex Litigation Blog - Recent Legal News

View updates for:
Published: October 7th, 2015
The federal court overseeing hundreds of Wright Conserve hip lawsuits has set a date for its first bellwether trial. According to an Order issued on September 21st in the U.S. District Court, Northern District of Georgia, the trial will begin on November 9th, to be preceded by a pretrial conference ...Read More
Published: October 1st, 2015
A Dallas County District Court jury is currently hearing arguments in the nation’s first trial of a transvaginal mesh lawsuit involving Ethicon, Inc.’s Prosima device. According to, the panel has already heard testimony from several plaintiff’s experts who claim that the Johnson &am...Read More
Published: September 23rd, 2015
The federal multidistrict litigation overseeing more 2,500 Xarelto lawsuits will begin trying cases in early 2017. According to an Order issued by the Court on September 18th, the first trial will begin on February 6, 2017, while subsequent trials will start on March 13th, April 24th and May 30th. ...Read More
Published: September 14th, 2015
A newly published study involving thousands of Risperdal patients has linked the drug to the development of gynecomastia, or excessive male breast growth. The publication of the research in the Journal of Child and Adolescent Psychopharmacology comes as the drugs’ manufacturers face hundreds of Ri...Read More
Published: September 9th, 2015
The U.S. Judicial Panel on Multidistrict Litigation (JPML) created several new multidistrict litigations last month, including two that involved medical products used to treat thousands of people. According to a Transfer Order dated August 14th, all federal IVC filter lawsuits involving C.R. Bard, I...Read More
Published: August 31st, 2015
The U.S. Food & Drug Administration (FDA) has issued a new alert pertaining to Onglyza and other dipeptidyl peptidase-4 (DPP-4) inhibitors, after the Type 2 diabetes medications were linked to severe and disabling joint pain. The joint pain alert was issued even as the agency works to complete i...Read More
Published: August 26th, 2015
Xarelto lawsuits continue to mount in the federal litigation now underway in the U.S. District Court, Eastern District of Louisiana. A case list recently issued by the U.S. Judicial Panel on Multidistrict Litigation indicates that, more than 1,230 claims had been filed proceeding as of August 15th. ...Read More
Published: August 17th, 2015
The U.S. Food & Drug Administration’s (FDA) regulation of medical devices is coming under renewed scrutiny, thanks to the ongoing controversy surrounding power morcellators and their potential to spread uterine cancer. Earlier this month, a dozen members of the U.S. Congress wrote to the Gover...Read More
Published: August 12th, 2015
C.R. Bard, Inc. may be preparing to settle as many as 3,000 transvaginal mesh lawsuits for a total of $200 million. According to a report from Bloomberg News, people familiar with the accord have said it would provide an average award of $67,000 per case. The vaginal mesh settlement program descr...Read More
Published: August 4th, 2015
Pharmacy benefit manager Express Scripts has decided to drop Onglyza from its 2016 formulary, after the Type 2 diabetes medication was linked to an increased risk of heart failure. The company is also excluding Kombiglyze XR for the same reason. Onglyza and Kombiglyze XR are both DPP-4 inhibitors...Read More